Truly moving the needle in clinical trial diversity comes down to embracing two fundamental pieces of the DE&I puzzle.
Pamela Tenaerts, MD
Advertisement
Chief Scientific Officer, Medable
Articles by Pamela Tenaerts, MD
Applied Clinical Trials
New recommendations offer guidance on overcoming legal, regulatory, and practical hurdles.
Advertisement
Latest Updated Articles
- Overcoming Barriers in Conducting Decentralized Clinical Trials
February 4th 2020
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The 10 Most Powerful Study KRIs in RBQM and GCP Issues They Can Prevent
2
AI Can Draft the CSR Faster, But Does That Make Drug Development Faster?
3
How China Cut Its Phase III Startup Timeline and What Drove the Change
4
ACT Brief: APAC Inspection Findings, RBQM Key Risk Indicators, and Head and Neck Cancer Approval
5